Alpha 2.0
Login Register
» Authors » Dilara C Ozkocak

Dilara C Ozkocak

Explore the profile of Dilara C Ozkocak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 106
Followers 0
Related Specialties
General Medicine
Biology
Pharmacology
Top 10 Co-Authors
Ivan K H Poon
Georgia K Atkin-Smith
Jascinta P Santavanond
Mark D Hulett
Sarah Caruso
Amy A Baxter
Thanh Kha Phan
Rochelle Tixeira
Lanzhou Jiang
Peter Lock
Published In
Apoptosis
J Extracell Vesicles
Mol Ther
Cell Death Dis
Front Immunol
Affiliations
Soon will be listed here.
Recent Articles
1.
In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions
Atkin-Smith G, Santavanond J, Light A, Rimes J, Samson A, Er J, et al.
Nat Commun . 2024 Oct; 15(1):8802. PMID: 39438460
Endothelial cells are integral components of all vasculature within complex organisms. As they line the blood vessel wall, endothelial cells are constantly exposed to a variety of molecular factors and...
2.
The small molecule raptinal can simultaneously induce apoptosis and inhibit PANX1 activity
Santavanond J, Chiu Y, Tixeira R, Liu Z, Yap J, Chen K, et al.
Cell Death Dis . 2024 Feb; 15(2):123. PMID: 38336804
Discovery of new small molecules that can activate distinct programmed cell death pathway is of significant interest as a research tool and for the development of novel therapeutics for pathological...
3.
Fighting fire with fire: Extracellular vesicles from pyroptotic mesenchymal stromal cells can dampen inflammation during sepsis
Ozkocak D, Poon I
Mol Ther . 2024 Jan; 32(2):275-276. PMID: 38246163
No abstract available.
4.
Translating extracellular vesicle packaging into therapeutic applications
Ozkocak D, Phan T, Poon I
Front Immunol . 2022 Sep; 13:946422. PMID: 36045692
Extracellular vesicles (EVs) are membrane-bound particles released by cells in various (patho)physiological conditions. EVs can transfer effector molecules and elicit potent responses in recipient cells, making them attractive therapeutic agents...
5.
Correction to: Defining the role of cytoskeletal components in the formation of apoptopodia and apoptotic bodies during apoptosis
Caruso S, Atkin-Smith G, Baxter A, Tixeira R, Jiang L, Ozkocak D, et al.
Apoptosis . 2019 Sep; 24(11-12):878. PMID: 31549272
The original version of the article unfortunately contained a typo in the fourth author name. The author name was incorrectly listed as Rochelle Tixeria. The correct name should be Rochelle...
6.
Defining the role of cytoskeletal components in the formation of apoptopodia and apoptotic bodies during apoptosis
Caruso S, Atkin-Smith G, Baxter A, Tixeira R, Jiang L, Ozkocak D, et al.
Apoptosis . 2019 Sep; 24(11-12):862-877. PMID: 31489517
During apoptosis, dying cells undergo dynamic morphological changes that ultimately lead to their disassembly into fragments called apoptotic bodies (ApoBDs). Reorganisation of the cytoskeletal structures is key in driving various...
7.
Moving beyond size and phosphatidylserine exposure: evidence for a diversity of apoptotic cell-derived extracellular vesicles
Poon I, Parkes M, Jiang L, Atkin-Smith G, Tixeira R, Gregory C, et al.
J Extracell Vesicles . 2019 May; 8(1):1608786. PMID: 31069027
Apoptosis is a form of programmed cell death that occurs throughout life as part of normal development as well as pathologic processes including chronic inflammation and infection. Although the death...